flecainide has been researched along with isoproterenol in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cockrell, JL; Griffin, JC; Helmy, I; Langberg, JJ; Lee, MA; Scheinman, MM; Titus, C | 1 |
| Griffin, JC; Helmy, I; Herre, JM; Scheinman, MM; Sharkey, H | 1 |
| Estes, NA; Manolis, AS | 1 |
| Admant, P; Brembilla-Perrot, B; Le Helloco, A; Pernot, C | 1 |
| Martin, CL; Mcmahon, EG; Palomo, MA | 1 |
| Cragun, KT; Johnson, SB; Packer, DL | 1 |
| Biffi, M; Boriani, G; Branzi, A; Bronzetti, G; Capucci, A; Magnani, B | 1 |
| Fan, L; Friedman, DM; Ovadia, M; Rifkind, AB | 1 |
| Avelino-Cruz, JE; Boyden, PA; Coetzee, WA; Denegri, M; Liu, N; Napolitano, C; Negri, S; Perissi, A; Priori, SG; Ruan, Y | 1 |
| Chang, CJ; Chen, SA; Chen, YC; Chen, YH; Chen, YJ; Kao, YH; Lin, YK; Lu, YY; Tsai, WC; Yang, LY | 1 |
| Bögeholz, N; Bogossian, H; Dechering, DG; Eckardt, L; Fehr, M; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Sterneberg, M | 1 |
| Chau, S; Miyamoto, SD; Nau, S; Phillips, EK; Stauffer, BL; Sucharov, CC; Tompkins, C; Wilson, CE; Woulfe, KC; Zang, S | 1 |
| Hoang, P; Jacquir, S; Lemus, S; Ma, Z | 1 |
| Fletcher, S; Gharanei, M; James, RS; Maddock, H; Wallis, R | 1 |
1 review(s) available for flecainide and isoproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for flecainide and isoproterenol
| Article | Year |
|---|---|
Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
Topics: Cardiac Pacing, Artificial; Electrophysiology; Flecainide; Heart Conduction System; Humans; Isoproterenol; Tachycardia, Atrioventricular Nodal Reentry | 1990 |
19 other study(ies) available for flecainide and isoproterenol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Child; Electric Stimulation; Female; Flecainide; Follow-Up Studies; Heart Diseases; Humans; Isoproterenol; Male; Middle Aged; Prospective Studies; Tachycardia, Atrioventricular Nodal Reentry | 1991 |
Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Electrophysiology; Female; Flecainide; Follow-Up Studies; Humans; Isoproterenol; Male; Middle Aged; Monitoring, Physiologic; Propranolol; Wolff-Parkinson-White Syndrome | 1989 |
Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Flecainide; Heart Block; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Piperidines; Wolff-Parkinson-White Syndrome | 1985 |
Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Flecainide; Guinea Pigs; Heart Atria; Isoproterenol; Male; Phenethylamines; Piperidines; Sulfonamides | 1996 |
Beta-adrenergic augmentation of flecainide-induced conduction slowing in canine Purkinje fibers.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Dogs; Female; Flecainide; Isoproterenol; Male; Membrane Potentials; Neural Conduction; Potassium; Protein Kinase C; Purkinje Fibers; Receptors, Adrenergic, beta; Sodium Channels | 1997 |
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
Topics: Adrenergic beta-Agonists; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Humans; Isoproterenol; Male; Middle Aged; Propafenone; Prospective Studies; Signal Processing, Computer-Assisted; Stimulation, Chemical | 1999 |
Ventricular preexcitation sensitive to flecainide in late stage chick embryo ECGs: 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs inotropic but not chronotropic or dromotropic responses to isoproterenol and confers resistance to flecainide.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chick Embryo; Drug Interactions; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Isoproterenol; Myocardial Contraction; Polychlorinated Dibenzodioxins; Teratogens; Ventricular Function | 2000 |
Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Signaling; Disease Models, Animal; Extracellular Space; Flecainide; Gene Knock-In Techniques; Isoproterenol; Mice; Mice, Mutant Strains; Myocytes, Cardiac; Patch-Clamp Techniques; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sodium Channels; Sympathomimetics; Tachycardia, Ventricular | 2011 |
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gene Knockout Techniques; Isoproterenol; Male; Mice; Mice, Knockout; Receptors, Androgen; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2015 |
Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Topics: Acetylcholine; Action Potentials; Animals; Antazoline; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Drug Discovery; Electrocardiography; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Rate; Histamine H1 Antagonists; Isolated Heart Preparation; Isoproterenol; Rabbits; Refractory Period, Electrophysiological; Time Factors | 2017 |
Acute isoproterenol leads to age-dependent arrhythmogenesis in guinea pigs.
Topics: Action Potentials; Age Factors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Disease Models, Animal; Female; Flecainide; Guinea Pigs; Heart Rate; Heart Ventricles; Isoproterenol; Male; Oxidation-Reduction; Phosphorylation; Ryanodine Receptor Calcium Release Channel; Time Factors; Ventricular Function, Left | 2018 |
Quantification of Contractile Dynamic Complexities Exhibited by Human Stem Cell-Derived Cardiomyocytes Using Nonlinear Dimensional Analysis.
Topics: Cells, Cultured; Electric Stimulation; Flecainide; Humans; Induced Pluripotent Stem Cells; Isoproterenol; Kinetics; Myocardial Contraction; Myocytes, Cardiac; Quinazolines | 2019 |
The cardiac work-loop technique: An in vitro model for identifying and profiling drug-induced changes in inotropy using rat papillary muscles.
Topics: Animals; Anthropometry; Atenolol; Cardiotonic Agents; Digoxin; Dobutamine; Electric Stimulation; Flecainide; In Vitro Techniques; Isometric Contraction; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Verapamil | 2020 |